The pharmacy chain and drugmaker are partnering to increase recruitment and improve diversity in clinical trials, according to a news release. The collaboration aims to increase Black and Hispanic representation in the studies, since these populations are more likely to have obesity and are underrepresented in clinical trials.
Boehringer Ingelheim is also working with EmVenio Research to roll out mobile research units.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.